Meningitis News and Research

Latest Meningitis News and Research

NMA urges parents to protect their children from meningococcal disease

This winter, while many parents are focused on influenza prevention, the National Meningitis Association (NMA) is urging parents to also protect their families from meningococcal disease, a deadly but potentially vaccine preventable bacterial infection.

22 Dec 2009

Survey examines disease R&D investment in 2008

According to an annual survey released Tuesday by the George Institute for International Health that looks at research and development (R&D) funding of diseases that affect the developing world, the U.S. government in 2008 "remained the single biggest contributor as it again provided almost half of the total funding but the report notes developing countries like Brazil [and] India ... were becoming a growing force," AAP/Sydney Morning Herald reports (Rose, 12/15).

17 Dec 2009

Pfizer's Prevenar 13 granted European marketing authorization

The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Invasive pneumococcal disease includes sepsis, meningitis, bacteremia, bacteremic pneumonia, and empyema.

11 Dec 2009

West Nile Virus can become more widespread in Europe than previously thought, says new report

Potentially fatal mosquito-borne West Nile fever (WNF) can become much more widespread in Europe than previously thought, say scientists in a new report just out in the journal BMC Evolutionary Biology(1).

8 Dec 2009

Patients with recurrent shoulder dislocations may benefit from new surgical technique

The shoulder is the most commonly dislocated joint in the human body, occurring most often in young, athletic people. New research from the University of Michigan Health System shows patients who have recurrent shoulder dislocations may benefit from surgical reconstruction using cadaver bone and cartilage to essentially 'sculpt' a new shoulder.

8 Dec 2009

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Ninety percent of all vaccine preventable deaths occur in those 65 and older, including residents in nursing homes, according to highlighted studies in the Pennsylvania Patient Safety Authority's 2009 December Patient Safety Advisory.

4 Dec 2009

Several new vaccines require booster shots to remain effective during a lifetime: Study

Preventing disease is the goal of every health care provider and fortunately every year, new vaccines are being added to assist in disease prevention. But do all vaccines boost immunity for the same period of time? And, if not, when are additional 'booster shots' needed to keep immunity strong?

24 Nov 2009

Climate change to have a profound impact on global public health

An emerging body of evidence suggests that the changing global climate is already affecting infectious disease transmission patterns. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), such changes are expected to have a profound impact on global public health.

21 Nov 2009

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Pfizer Inc announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children.

19 Nov 2009

MSF's volunteer physicians receive free access to Elsevier's electronic CDS tool

The physicians of the world renowned Doctors Without Borders/Medecins Sans Frontieres (MSF), which won the Nobel Peace Prize in 1999, will receive free access to MD Consult (www.mdconsult.com), Elsevier's premier electronic clinical decision support (CDS) tool, as the result of a special new Elsevier campaign.

18 Nov 2009

Regulatory agencies offer marketing approval for new products to treat neglected diseases

New products to treat neglected diseases have received marketing approval from regulatory agencies at a steadily increasing rate in recent years as R&D funding for those diseases has increased, according to a recently completed study by the Tufts Center for the Study of Drug Development.

18 Nov 2009

UT physicians treat Iraqi girl with myasthenia gravis

Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be.

16 Nov 2009

Exposure to deadly bacteria can result in stillbirths

A new study shows the risk for severe effects of exposure to Listeria monocytogenes among susceptible populations may occur at doses lower than suggested by previous studies.

13 Nov 2009

2009 H1N1 influenza PPE federal guidance for healthcare workers causes concern among prevention experts

Three leading scientific organizations specializing in infectious diseases prevention issued a letter to President Obama today expressing their significant concern with current federal guidance concerning the use of personal protective equipment (PPE) by healthcare workers in treating suspected or confirmed cases of 2009 H1N1 influenza.

7 Nov 2009

WHO, MSF highlight poor health situation in Southern Sudan

Three quarters of people in South Sudan, which has a population of 8 million, do not have access to health care, and 10 percent of children there and in Darfur die before the age of 1, Mohammad Abdur Rab, the WHO's representative to Sudan, said Thursday, Reuters/ABC News reports.

7 Nov 2009

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses.

31 Oct 2009

New York Times examines efforts underway to prevent spread of H1N1 during Hajj

The New York Times examines how Saudi Arabia is preparing for the upcoming annual pilgrimage of some "2.5 million people from 160 countries" to Mecca, some who "will be bringing the swine flu. The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off," the newspaper writes.

31 Oct 2009

sanofi-aventis reports financial results for the third quarter of 2009

In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.

30 Oct 2009

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID).

27 Oct 2009

Fero Industries to complete acquisition of Pyro Pharmaceuticals by November 30, 2009

Fero Industries, Inc. is pleased to provide certain disclosures relating to the ten pending patent applications of Pyro Pharmaceuticals, Inc. As previously announced, the Company has initiated the process of acquiring Pyro Pharmaceuticals, Inc. through an exchange of Pyro’s capital stock for shares of the Company’s common stock, with Fero remaining as the parent entity and Pyro as a subsidiary. The acquisition of Pyro is expected to close by November 30, 2009.

27 Oct 2009

Meningitis News and Research

Latest Meningitis News and Research

NMA urges parents to protect their children from meningococcal disease

Survey examines disease R&D investment in 2008

Pfizer's Prevenar 13 granted European marketing authorization

West Nile Virus can become more widespread in Europe than previously thought, says new report

Patients with recurrent shoulder dislocations may benefit from new surgical technique

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Several new vaccines require booster shots to remain effective during a lifetime: Study

Climate change to have a profound impact on global public health

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

MSF's volunteer physicians receive free access to Elsevier's electronic CDS tool

Regulatory agencies offer marketing approval for new products to treat neglected diseases

UT physicians treat Iraqi girl with myasthenia gravis

Exposure to deadly bacteria can result in stillbirths

2009 H1N1 influenza PPE federal guidance for healthcare workers causes concern among prevention experts

WHO, MSF highlight poor health situation in Southern Sudan

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

New York Times examines efforts underway to prevent spread of H1N1 during Hajj

sanofi-aventis reports financial results for the third quarter of 2009

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

Fero Industries to complete acquisition of Pyro Pharmaceuticals by November 30, 2009

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Meningitis News and Research

Latest Meningitis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in